The ACR’s quality measures for care include gauging disease activity and functional status via patient-reported outcomes (PROs) and clinical assessments during routine care.1 But how do rheumatologists effectively incorporate PROs into a clinic visit? Christie Bartels, MD, MS, chief of the Division of Rheumatology and associate professor in the Department of Medicine, University of Wisconsin…
With three new endowments established, the ACR Rheumatology Research Foundation aims to support and inspire the future of rheumatology and the innovative research that will one day benefit patients.
ACR Open Rheumatology Editor-in-Chief Andras Perl, MD, PhD, discusses his unique career and his approach to balancing basic and translational research articles with outcome-focused articles within the journal.
Why this research is relevant to clinicians today & researchers in the future WASHINGTON, D.C.—The ACR Convergence 2024 meeting in Washington, D.C., reflected the continued advancement of science and practical research in the field of rheumatoid arthritis. Highlights this year centered on new RA treatments and new uses of existing treatments; the use of artificial…
Virtual reality technology may be a unique and immersive avenue for educating patients on rheumatic conditions and their treatments, with the potential to enable more informed decision making and improve care.
Physicians have a lot going on. Between the pressures of clinical and administrative responsibilities, sometimes the only way to keep everything together is with a to-do list. Unfortunately, it can often feel as though some items never come off that list. Often, the bigger a project sounds, the more likely it is to sit on…
Based on research in post-surgery patients, the FDA approved suzetrigine, a non-opioid analgesic, for the treatment moderate to severe, acute pain in adults.